Investor...if we could only get Scott back to carry the mail for Anavex and 2-73/3-71 in the attack on neurodegenerative diseases. But, I believe we will soon get some deep thinkers at the EMA and FDA who will champion what our drugs accomplish thru the Sigma1 approach. It is always "darkest just before the dawn".